MP-470 regulatory update

FDA granted Orphan Drug designation for oral MP-470 to treat glioblastoma multiforme (GBM). The multi-targeted tyrosine kinase inhibitor (TKI) that suppresses c-Met, c-Ret and the Rad51 protein is in...